Get the Stockscreener App
9.07
2.14%
0.19
Certara Inc stock is traded at $9.07, with a volume of 3.78M.
It is up +2.14% in the last 24 hours and up +9.41% over the past month.
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval and increase patient access to medicines. The company has its business presence in the Americas which is also it key revenue generating market, EMEA and Asia Pacific region.
See More
Previous Close:
$8.88
Open:
$8.93
24h Volume:
3.78M
Relative Volume:
1.73
Market Cap:
$1.44B
Revenue:
$405.76M
Net Income/Loss:
$7.98M
P/E Ratio:
181.40
EPS:
0.05
Net Cash Flow:
$77.47M
1W Performance:
+5.71%
1M Performance:
+9.41%
6M Performance:
-14.19%
1Y Performance:
-14.03%
1-Day Range:
$8.93
$9.155
1-Week Range:
$8.4161
$9.17
52-Week Range:
$8.025
$15.69
Certara Inc Stock (CERT) Company Profile
Name
Certara Inc
Sector
Industry
Phone
(415) 237-8272
Address
4 RADNOR CORPORATE CENTER, SUITE 350, RADNOR
Compare CERT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CERT
Certara Inc
|
9.07 | 1.41B | 405.76M | 7.98M | 77.47M | 0.05 |
|
VEEV
Veeva Systems Inc
|
221.86 | 35.85B | 3.08B | 860.33M | 1.35B | 5.1463 |
|
TEM
Tempus Ai Inc
|
64.46 | 11.07B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
43.65 | 8.19B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
95.50 | 8.16B | 1.15B | 96.70M | -161.99M | 1.09 |
|
BTSG
Brightspring Health Services Inc
|
37.49 | 6.61B | 11.99B | 24.18M | 234.31M | 0.2956 |
Certara Inc Stock (CERT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-21-25 | Initiated | Rothschild & Co Redburn | Buy |
| Nov-13-25 | Initiated | BMO Capital Markets | Market Perform |
| Sep-29-25 | Initiated | Craig Hallum | Buy |
| Jul-03-25 | Resumed | Morgan Stanley | Equal-Weight |
| May-08-25 | Upgrade | Barclays | Equal Weight → Overweight |
| Feb-27-25 | Initiated | TD Cowen | Buy |
| Sep-27-24 | Upgrade | UBS | Neutral → Buy |
| Apr-10-24 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Apr-04-24 | Initiated | JMP Securities | Mkt Perform |
| Feb-26-24 | Initiated | Leerink Partners | Market Perform |
| Dec-07-23 | Initiated | UBS | Neutral |
| Dec-05-23 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Aug-22-23 | Downgrade | Jefferies | Buy → Hold |
| Aug-10-23 | Downgrade | William Blair | Outperform → Mkt Perform |
| Apr-12-23 | Initiated | Stephens | Overweight |
| Apr-03-23 | Downgrade | Barclays | Overweight → Equal Weight |
| Dec-14-22 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Sep-08-22 | Initiated | Berenberg | Buy |
| Aug-25-22 | Initiated | Credit Suisse | Outperform |
| Jul-01-22 | Initiated | Piper Sandler | Overweight |
| Jan-11-22 | Upgrade | Jefferies | Hold → Buy |
| Aug-05-21 | Resumed | Credit Suisse | Neutral |
| Jul-23-21 | Initiated | Robert W. Baird | Outperform |
| Mar-03-21 | Initiated | Barclays | Overweight |
| Jan-06-21 | Initiated | Morgan Stanley | Equal-Weight |
| Jan-05-21 | Initiated | BofA Securities | Buy |
| Jan-05-21 | Initiated | Credit Suisse | Neutral |
| Jan-05-21 | Initiated | Jefferies | Hold |
| Jan-05-21 | Initiated | William Blair | Outperform |
View All
Certara Inc Stock (CERT) Latest News
Risk Check: Why Certara Inc stock remains a top recommendationJuly 2025 Big Picture & Fast Gain Stock Tips - moha.gov.vn
Why Certara Inc. stock appeals to analystsJuly 2025 Update & Accurate Intraday Trade Tips - Улправда
What momentum indicators show for Certara Inc. stockMarket Growth Summary & Safe Capital Growth Tips - Улправда
Is Certara Inc. stock a buy before product launchesJuly 2025 Setups & Smart Investment Allocation Tips - Улправда
Can Certara Inc. stock surprise with earnings upsideJuly 2025 Chart Watch & AI Based Trade Execution Alerts - Улправда
Certara (CERT): Morgan Stanley Lowers Price Target to $12.00 | C - GuruFocus
Certara (NASDAQ:CERT) Given New $12.00 Price Target at Morgan Stanley - MarketBeat
Does Certara’s (CERT) New IQVIA-Trained CEO Mark a Strategic Shift in Its Biosimulation Focus? - simplywall.st
Barclays Lowers Price Target for Certara (CERT) to $13, Maintains Overweight Rating | CERT Stock News - GuruFocus
Analysts Are Bullish on Top Healthcare Stocks: Certara (CERT), Sera Prognostics (SERA) - The Globe and Mail
Certara, Inc. (NASDAQ:CERT) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future? - 富途牛牛
Stephens Cuts Certara (NASDAQ:CERT) Price Target to $12.00 - Defense World
Certara appoints Jon Resnick as new CEO; reaffirms FY25 outlook - MSN
(CERT) Movement as an Input in Quant Signal Sets - news.stocktradersdaily.com
Certara, Inc.Common Stock (Nasdaq:CERT) Stock Quote - Markets Financial Content
Stephens & Co. maintains Certara (CERT) overweight recommendation - MSN
AI Creation Engines Transform Biotech as Wellness Tech Captures Growth Wave - marketscreener.com
CERT: Stephens & Co. Lowers Price Target on Certara, Maintains O - GuruFocus
Certara stock price target lowered to $12 at Stephens on CEO transition - Investing.com Nigeria
CERT Reaffirms FY25 Revenue and EBITDA Margin Outlook - GuruFocus
Will Certara’s (CERT) New IQVIA-Veteran CEO Reframe Its Biosimulation and AI Leadership Story? - Yahoo Finance
Certara (CERT) Valuation Check as New CEO Jon Resnick Takes Over and Outlook Is Reaffirmed - Yahoo Finance
Does Certara Inc (CERT) offer a good opportunity for investors? - setenews.com
Certara Appoints Jon Resnick as Chief Executive Officer - citybiz
Certara, Inc. Announces Board Changes - marketscreener.com
Certara, Inc. Announces CEO Changes - marketscreener.com
Certara Names Jon Resnick as Chief Executive, Reaffirms 2025 Guidance - marketscreener.com
CERT FinancialsIncome Statement - Quiver Quantitative
Certara names Jon Resnick as new CEO, effective January 2026 - Investing.com
Certara, Inc. Announces CEO Transition - TradingView — Track All Markets
Certara appoints Jon Resnick as chief executive officer - marketscreener.com
Certara, Inc. Appoints Jon Resnick as CEO, Succeeding William Feehery, Effective January 1, 2026 - Quiver Quantitative
Certara (NASDAQ: CERT) appoints Jon Resnick as CEO and board member - Stock Titan
Certara Appoints Jon Resnick as Chief Executive Officer - GlobeNewswire Inc.
Earnings estimates moving higher for Certara (CERT): Time to buy? - MSN
Recent Research Analysts’ Ratings Changes for Certara (CERT) - Defense World
Certara, Inc. $CERT Holdings Lifted by Marshall Wace LLP - MarketBeat
2Xideas AG Sells 223,506 Shares of Certara, Inc. $CERT - Defense World
Wall Street analysts think Certara (CERT) could surge 43.28%: Read this before placing a bet - MSN
Do Options Traders Know Something About CERT Stock We Don't? - TradingView — Track All Markets
Earnings Estimates Moving Higher for Certara (CERT): Time to Buy? - Eastern Progress
Wall Street Analysts Think Certara (CERT) Could Surge 43.28%: Read This Before Placing a Bet - Yahoo Finance
Does Certara (NASDAQ:CERT) Have A Healthy Balance Sheet? - simplywall.st
How Recent Developments Are Rewriting the Story for Certara’s Biosimulation Leadership - Yahoo Finance
Stocks of Certara Inc (CERT) are poised to climb above their peers - setenews.com
Why Certara Inc. stock is favored by top institutionsJuly 2025 Technicals & Fast Exit and Entry Trade Guides - Newser
Liquidity Mapping Around (CERT) Price Events - news.stocktradersdaily.com
Samjo Management LLC Lowers Position in Certara, Inc. $CERT - MarketBeat
Certara, Inc. $CERT Shares Bought by Mackenzie Financial Corp - MarketBeat
How Certara Inc. stock benefits from strong dollarJuly 2025 Action & Smart Allocation Stock Tips - Newser
Intech Investment Management LLC Makes New $329,000 Investment in Certara, Inc. $CERT - Defense World
Certara Inc Stock (CERT) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.28%
1.25%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):